The following articles (labelled with PubMed ID or TBD) are for your review
| PMID | Data | Article Title | Organization |
|---|
| 28148462 |
124 |
Exploration of phenylpropanoic acids as agonists of the free fatty acid receptor 4 (FFA4): Identification of an orally efficacious FFA4 agonist. |
Glaxosmithkline |
| 28105274 |
108 |
Design, Synthesis, and Evaluation of Novel and Selective G-protein Coupled Receptor 120 (GPR120) Spirocyclic Agonists. |
Merck |
| 28105282 |
95 |
Discovery of Chromane Propionic Acid Analogues as Selective Agonists of GPR120 with |
Merck |
| 27815121 |
132 |
Discovery of benzofuran propanoic acid GPR120 agonists: From uHTS hit to mechanism-based pharmacodynamic effects. |
Merck |
| 27570890 |
57 |
Non-Acidic Free Fatty Acid Receptor 4 Agonists with Antidiabetic Activity. |
University of Southern Denmark |
| 24881566 |
140 |
Identification of diarylsulfonamides as agonists of the free fatty acid receptor 4 (FFA4/GPR120). |
Glaxosmithkline |
| 22519963 |
80 |
Discovery of a potent and selective GPR120 agonist. |
University of Southern Denmark |
| 29456108 |
40 |
Discovery of N-arylpyrroles as agonists of GPR120 for the treatment of type II diabetes. |
Janssen Research and Development |
| 28947942 |
55 |
Discovery of an Isothiazole-Based Phenylpropanoic Acid GPR120 Agonist as a Development Candidate for Type 2 Diabetes. |
Janssen Research and Development |
| 28374589 |
73 |
Indazole-6-phenylcyclopropylcarboxylic Acids as Selective GPR120 Agonists with in Vivo Efficacy. |
Astrazeneca |
Search and Browse
